{"url_path":"/sec/ptix/8-k/2026-02-24/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-24","source_url":"https://www.sec.gov/Archives/edgar/data/1022899/0001493152-26-007800-index.html","accession_number":"0001493152-26-007800","cik":"0001022899","ticker":"PTIX","issuer_name":"Protagenic Therapeutics, Inc.\\new","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022899/0001493152-26-007800-index.html","primary_entity_key":"0001022899","primary_entity_name":"Protagenic Therapeutics, Inc.\\new"},"word_count":419,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits**\n\n \n\n(d)\nExhibits\n\n \n\nExhibit\n10.1 – [Settlement Agreement, dated February 13, 2026](ex10-1.htm)\n\nExhibit 10.2 – [Unwind, Termination and Share Exchange Agreement, dated February 17, 2026](ex10-2.htm)\n\nExhibit 104 – Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.\n\n \n\n**Forward-Looking\nStatements**\n\n \n\nThis\nCurrent Report on Form 8-K contains “forward-looking statements” within the meaning of the U.S. federal securities laws.\nForward-looking statements can be identified by words such as “projects,” “may,” “will,” “could,”\n“would,” “should,” “believes,” “expects,” “anticipates,” “estimates,”\n“intends,” “plans,” “potential,” “promise” or similar references to future periods. Examples\nof forward-looking statements in this current report include, without limitation, statements regarding the Company’s available\noptions to resolve the deficiency and regain compliance with Nasdaq listing rules. Forward-looking statements are statements that are\nnot historical facts nor assurances of future performance. Instead, they are based on the Company’s current beliefs, expectations\nand assumptions regarding the future of its business, future plans, strategies, projections, anticipated events and trends, the economy\nand other future conditions. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties,\nand actual results may differ materially from those set forth in the forward-looking statements. Important factors that could cause actual\nresults to differ include, without limitation, that there can be no assurance that the Company will file the Form 10-Q, that there can\nbe no assurance that the Company will otherwise meet Nasdaq compliance standards, that there can be no assurance that Nasdaq will grant\nthe Company any relief from delisting as necessary or whether the Company can agree to or ultimately meet applicable Nasdaq requirements\nfor any such relief, and the other important factors described under the caption “Risk Factors” in the Company’s filings\nwith the SEC. Any forward-looking statement made by the Company in this current report is based only on information currently available\nand speaks only as of the date on which it is made. Except as required by applicable law, the Company expressly disclaims any obligation\nto publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of\nnew information, future developments or otherwise.\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \nPROTAGENIC\nTHERAPEUTICS, INC.\n\n \n \n \n\nDate:\nFebruary 23, 2026\nBy:\n*/s/\nAlexander K. Arrow*\n\n \nName:\nAlexander\nK. Arrow\n\n \nTitle:\nChief\nFinancial Officer"}